Christoph Thomssen
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Estrogen and related hormone effects
Most-Cited Works
- → Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer(2005)5,074 cited
- → 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)(2016)2,058 cited
- → 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)(2020)1,319 cited
- → 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)(2018)1,168 cited
- → Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients(2002)602 cited
- → Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study(2010)553 cited
- → ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)(2014)538 cited
- → Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1(2001)438 cited
- → Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for Therapy(1997)387 cited
- → Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy: Results From an International Collaborative Study(2013)367 cited